chr12-2668972-A-ACAGT
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1PM2
The NM_000719.7(CACNA1C):c.4666_4669dupGTCA(p.Met1557SerfsTer28) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000719.7 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.4666_4669dupGTCA | p.Met1557SerfsTer28 | frameshift_variant | Exon 38 of 47 | ENST00000399655.6 | NP_000710.5 | |
CACNA1C | NM_001167623.2 | c.4666_4669dupGTCA | p.Met1557SerfsTer28 | frameshift_variant | Exon 38 of 47 | ENST00000399603.6 | NP_001161095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.4666_4669dupGTCA | p.Met1557SerfsTer28 | frameshift_variant | Exon 38 of 47 | 5 | NM_001167623.2 | ENSP00000382512.1 | ||
CACNA1C | ENST00000399655.6 | c.4666_4669dupGTCA | p.Met1557SerfsTer28 | frameshift_variant | Exon 38 of 47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
CACNA1C | ENST00000682544.1 | c.4900_4903dupGTCA | p.Met1635SerfsTer28 | frameshift_variant | Exon 40 of 50 | ENSP00000507184.1 | ||||
CACNA1C | ENST00000406454.8 | c.4666_4669dupGTCA | p.Met1557SerfsTer28 | frameshift_variant | Exon 38 of 48 | 5 | ENSP00000385896.3 | |||
CACNA1C | ENST00000399634.6 | c.4633_4636dupGTCA | p.Met1546SerfsTer28 | frameshift_variant | Exon 37 of 47 | 5 | ENSP00000382542.2 | |||
CACNA1C | ENST00000683824.1 | c.4831_4834dupGTCA | p.Met1612SerfsTer28 | frameshift_variant | Exon 39 of 48 | ENSP00000507867.1 | ||||
CACNA1C | ENST00000347598.9 | c.4810_4813dupGTCA | p.Met1605SerfsTer28 | frameshift_variant | Exon 40 of 49 | 1 | ENSP00000266376.6 | |||
CACNA1C | ENST00000344100.7 | c.4732_4735dupGTCA | p.Met1579SerfsTer33 | frameshift_variant | Exon 38 of 47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000327702.12 | c.4666_4669dupGTCA | p.Met1557SerfsTer28 | frameshift_variant | Exon 38 of 48 | 1 | ENSP00000329877.7 | |||
CACNA1C | ENST00000399617.6 | c.4666_4669dupGTCA | p.Met1557SerfsTer28 | frameshift_variant | Exon 38 of 48 | 5 | ENSP00000382526.1 | |||
CACNA1C | ENST00000682462.1 | c.4756_4759dupGTCA | p.Met1587SerfsTer28 | frameshift_variant | Exon 38 of 47 | ENSP00000507105.1 | ||||
CACNA1C | ENST00000683781.1 | c.4756_4759dupGTCA | p.Met1587SerfsTer28 | frameshift_variant | Exon 38 of 47 | ENSP00000507434.1 | ||||
CACNA1C | ENST00000683840.1 | c.4756_4759dupGTCA | p.Met1587SerfsTer28 | frameshift_variant | Exon 38 of 47 | ENSP00000507612.1 | ||||
CACNA1C | ENST00000683956.1 | c.4756_4759dupGTCA | p.Met1587SerfsTer28 | frameshift_variant | Exon 38 of 47 | ENSP00000506882.1 | ||||
CACNA1C | ENST00000399638.5 | c.4750_4753dupGTCA | p.Met1585SerfsTer28 | frameshift_variant | Exon 39 of 48 | 1 | ENSP00000382547.1 | |||
CACNA1C | ENST00000335762.10 | c.4741_4744dupGTCA | p.Met1582SerfsTer28 | frameshift_variant | Exon 39 of 48 | 5 | ENSP00000336982.5 | |||
CACNA1C | ENST00000399606.5 | c.4726_4729dupGTCA | p.Met1577SerfsTer28 | frameshift_variant | Exon 39 of 48 | 1 | ENSP00000382515.1 | |||
CACNA1C | ENST00000399621.5 | c.4666_4669dupGTCA | p.Met1557SerfsTer33 | frameshift_variant | Exon 38 of 47 | 1 | ENSP00000382530.1 | |||
CACNA1C | ENST00000399637.5 | c.4666_4669dupGTCA | p.Met1557SerfsTer33 | frameshift_variant | Exon 38 of 47 | 1 | ENSP00000382546.1 | |||
CACNA1C | ENST00000402845.7 | c.4666_4669dupGTCA | p.Met1557SerfsTer33 | frameshift_variant | Exon 38 of 47 | 1 | ENSP00000385724.3 | |||
CACNA1C | ENST00000399629.5 | c.4717_4720dupGTCA | p.Met1574SerfsTer28 | frameshift_variant | Exon 38 of 47 | 1 | ENSP00000382537.1 | |||
CACNA1C | ENST00000682336.1 | c.4708_4711dupGTCA | p.Met1571SerfsTer28 | frameshift_variant | Exon 38 of 47 | ENSP00000507898.1 | ||||
CACNA1C | ENST00000399591.5 | c.4633_4636dupGTCA | p.Met1546SerfsTer33 | frameshift_variant | Exon 37 of 46 | 1 | ENSP00000382500.1 | |||
CACNA1C | ENST00000399595.5 | c.4633_4636dupGTCA | p.Met1546SerfsTer33 | frameshift_variant | Exon 37 of 46 | 1 | ENSP00000382504.1 | |||
CACNA1C | ENST00000399649.5 | c.4627_4630dupGTCA | p.Met1544SerfsTer33 | frameshift_variant | Exon 37 of 46 | 1 | ENSP00000382557.1 | |||
CACNA1C | ENST00000399597.5 | c.4666_4669dupGTCA | p.Met1557SerfsTer28 | frameshift_variant | Exon 38 of 47 | 1 | ENSP00000382506.1 | |||
CACNA1C | ENST00000399601.5 | c.4666_4669dupGTCA | p.Met1557SerfsTer28 | frameshift_variant | Exon 38 of 47 | 1 | ENSP00000382510.1 | |||
CACNA1C | ENST00000399641.6 | c.4666_4669dupGTCA | p.Met1557SerfsTer28 | frameshift_variant | Exon 38 of 47 | 1 | ENSP00000382549.1 | |||
CACNA1C | ENST00000399644.5 | c.4666_4669dupGTCA | p.Met1557SerfsTer28 | frameshift_variant | Exon 38 of 47 | 1 | ENSP00000382552.1 | |||
CACNA1C | ENST00000682835.1 | c.4666_4669dupGTCA | p.Met1557SerfsTer28 | frameshift_variant | Exon 38 of 47 | ENSP00000507282.1 | ||||
CACNA1C | ENST00000683482.1 | c.4657_4660dupGTCA | p.Met1554SerfsTer28 | frameshift_variant | Exon 38 of 47 | ENSP00000507169.1 | ||||
CACNA1C | ENST00000682686.1 | c.4633_4636dupGTCA | p.Met1546SerfsTer28 | frameshift_variant | Exon 37 of 46 | ENSP00000507309.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Long QT syndrome Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change creates a premature translational stop signal (p.Met1557Serfs*28) in the CACNA1C gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in CACNA1C cause disease. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CACNA1C-related conditions. ClinVar contains an entry for this variant (Variation ID: 835382). -
Cardiovascular phenotype Uncertain:1
The c.4666_4669dupGTCA variant, located in coding exon 38 of the CACNA1C gene, results from a duplication of GTCA at nucleotide position 4666, causing a translational frameshift with a predicted alternate stop codon (p.M1557Sfs*28). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. However, loss of function of CACNA1C has not been clearly established as a mechanism of disease. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at